Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Neuromodulation. 2020 Sep 17;24(5):870–878. doi: 10.1111/ner.13256

Table 2.

Anger and sleep quality scores for intent-to-treat samples across time points.

Active TBS (n=25) Sham TBS (n=25) p value a
DAR (mean, SD)
 Baseline 11.50 (6.3) 14.10 (5.6) 0.13
 Midpoint double blind 9.06 (6.3) 13.22 (5.5) 0.02b
 Endpoint double blind 9.43 (6.6) 12.74 (5.9) 0.07
 Midpoint open label 8.77 (6.8) 11.61 (6.5) 0.14
 Endpoint open label 7.76 (6.8) 9.33 (6.5) 0.41
 Follow-up 8.18 (6.5) 10.88 (6.9) 0.17
PSQI (mean, SD)
 Baseline 14.04 (2.9) 13.84 (4.7) 0.86
 Midpoint double blind 11.67 (4.0) 12.83 (4.3) 0.34
 Endpoint double blind 11.33 (3.9) 12.63 (4.8) 0.31
 Midpoint open label 10.58 (3.7) 12.05 (4.9) 0.26
 Endpoint open label 10.22 (3.6) 11.05 (5.1) 0.54
 Follow-up 9.52 (3.3) 10.24 (4.8) 0.58

Abbreviations: SD, Standard deviation; DAR, Dimensions of Anger Reactions scale; PSQI, Pittsburgh Sleep Quality Index.

a

p values represent independent samples t-test between group differences.

b

denotes p<0.05